Your browser doesn't support javascript.
loading
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in Japan.
Oki, Yasuhiro; Kondo, Yutaka; Yamamoto, Kazuhito; Ogura, Michinori; Kasai, Masanobu; Kobayashi, Yukio; Watanabe, Takashi; Uike, Naokuni; Ohyashiki, Kazuma; Okamoto, Shin-ichiro; Ohnishi, Kazunori; Tomita, Akihiro; Miyazaki, Yasushi; Tohyama, Kaoru; Mukai, Harumi Y; Hotta, Tomomitsu; Tomonaga, Masao.
Affiliation
  • Oki Y; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan. yoki@mdanderson.org
Cancer Sci ; 103(10): 1839-47, 2012 Oct.
Article in En | MEDLINE | ID: mdl-22816487
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Sci Year: 2012 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Myelodysplastic Syndromes / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Sci Year: 2012 Document type: Article Affiliation country: Japan Country of publication: United kingdom